METABOLIC CONTROL WORSENS WITH INCREASING FIBROSIS STAGE IN PATIENTS WITH PRE-CIRRHOTIC NONALCOHOLIC STEATOHEPATITIS (NASH): COMBINED DATA FROM MULTIPLE THERAPEUTIC CLINICAL TRIALS INCLUDING MORE THAN 6,000 PATIENTS (WITH THE COLLABORATION OF NAIL-NIT CONSORTIUM)

被引：0
|
作者：
Schattenberg, Joern M. [1 ]
Dubourg, Julie [2 ]
Harrison, Stephen A. [3 ]
Alkhouri, Naim [4 ]
Jeannin, Sophie [2 ]
Noureddin, Mazen [5 ]
机构：
[1] Johannes Gutenberg Univ Mainz, Mainz, Germany
[2] Summit Clin Res, San Antonio, TX USA
[3] Univ Oxford, Radcliffe Dept Med, Oxford, England
[4] Arizona Liver Hlth, Phoenix, AZ USA
[5] Houston Res Inst, Houston, TX USA
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2221-A
引用
收藏
页码：S1006 / S1009
页数：4
相关论文
共 23 条
  • [21] GLYCEMIC CONTROL PREDICTS ADVANCED FIBROSIS IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): COMBINED DATA FROM MULTIPLE THERAPEUTIC TRIALS INCLUDING MORE THAN 4,000 LIVER BIOPSY DATA
    Rinella, Mary
    Dubourg, Julie
    Ratziu, Vlad
    Alkhouri, Naim
    Jeannin, Sophie
    Schattenberg, Joern
    Noureddin, Mazen
    Charlton, Michael
    Harrison, Stephen
    HEPATOLOGY, 2024, 80 : S649 - S650
  • [22] Clinical, biological and imaging predictors of advanced fibrosis (F3-F4): combined data frommultiple therapeutic trials including more than 10, 000 patients
    Noureddin, Mazen
    Alkhouri, Naim
    Ratziu, Vlad
    Schattenberg, Jorn M.
    Charlton, Michael
    Dubourg, Julie
    Harrison, Stephen A.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S507 - S508
  • [23] Clinical and biological predictors of liver fat content ≥8% as assessed by MRI-PDFF: combined data from multiple therapeutic trials including more than 10, 000 patients
    Noureddin, Mazen
    Jeannin, Sophie
    Alkhouri, Naim
    Ratziu, Vlad
    Schattenberg, Jorn M.
    Charlton, Michael
    Dubourg, Julie
    Harrison, Stephen A.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S518 - S518
123